REUTERS
February 17, 2021 at 17:40 JST
People wearing face masks to help curb the spread of the coronavirus walk under the cherry blossoms at the last day of Chinese Lunar New Year celebration in Taipei, Taiwan, on Feb. 16. (AP Photo)
TAIPEI--A deal for Taiwan to buy 5 million doses of a COVID-19 vaccine developed by Germany’s BioNTech SE is on hold, the island’s health minister said on Wednesday, citing potential Chinese pressure for the delay.
Taiwan Health Minister Chen Shih-chung said officials were on the verge of announcing the deal in December when BioNTech pulled the plug.
While he did not directly say China was to blame, Chen implied there was a political dimension to the decision and that he had been worried about “outside forces intervening,” hence his caution in discussing the planned deal publicly.
“Certain people don’t want Taiwan to be too happy,” he added, without elaborating, in a radio interview.
China, which claims Taiwan as its own territory, has repeatedly sparred with the island over the coronavirus pandemic.
Taiwan has been angered by China’s assertion only it can speak for the island on the international stage about the subject, while Taiwan has accused China of lack of transparency.
BioNTech signed a deal with Chinese firm Shanghai Fosun Pharmaceutical Group Co. Ltd. to exclusively develop and commercialize COVID-19 vaccine products developed by using BioNTech’s mRNA technology in mainland China, Hong Kong, Macau and Taiwan.
In return it agreed to pay up to $85 million in licensing fees and invest $50 million for a stake in the German firm.
BioNTech’s development and distribution partner for the rest of the world is U.S. firm Pfizer Inc.
Chen said BioNTech had not asked them to speak to Fosun, and the deal with BioNTech had not been “torn up,” only that it was “pending.”
BioNTech and Fosun did not immediately respond to a request for comment. China’s Taiwan Affairs Office declined immediate comment. China is currently observing the week-long Lunar New Year holiday.
Taiwan announced late in December said it had agreed to buy almost 20 million doses of COVID-19 vaccine, including 10 million from UK drugmaker AstraZeneca, with the rest coming from the COVAX global vaccine program and an unnamed company.
Fosun Pharma to buy 100 million doses of BioNTech’s COVID-19 vaccine for mainland China
December 16, 2020China’s Fosun to end BioNTech’s COVID-19 vaccine trial, seek approval for another
November 4, 2020Tibet Rhodiola Pharma obtains right to develop Russia’s Sputnik-V vaccine in China
November 12, 2020
How Pfizer vaccine could be cold comfort for some Asian nations
November 11, 2020
FACTBOX: When and which COVID-19 vaccines are likely to be available in Asia
November 27, 2020
Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan
August 1, 2020
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
